WallStSmart
KOD

Kodiak Sciences Inc

NASDAQ: KOD · HEALTHCARE · BIOTECHNOLOGY

$33.22
+5.39% today

Updated 2026-09-24

Market cap
$2.12B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.37
Dividend yield
—
52W range
$11 – $48
Volume
0.6M

WallStSmart proprietary scores

25
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
4.0
Quality
C
3.0
Profitability
D
5.0
Valuation
C+
1/9
Piotroski F-Score
Weak
-7.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →260 stocks currently score above 75

Price targets

Analyst target
$69.60
+109.51%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths
Insufficient data
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -7.30 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-46.59M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-333.82M$-260.49M$-176.21M$-229.97M$-65.64M
EPS————$-4.37
Free cash flow$-253.82M$-195.61M$-117.72M$-136.51M$-46.59M
Profit margin—————

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
KOD$2.12B254.33.05.04.0—Avoid
LLY$1.03T769.310.05.06.0—Strong Buy
JNJ$648.67B594.78.53.75.5—Buy
ABBV$454.36B736.78.54.05.0-73.51%Strong Buy
MRK$365.34B364.04.52.05.0-78.20%Hold
UNH$333.27B627.35.55.35.5-14.85%Buy

Smart narrative

Kodiak Sciences Inc trades at $33.22. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -7.30, it sits in the distress.

Frequently asked questions

What is Kodiak Sciences Inc's stock price?

Kodiak Sciences Inc (KOD) trades at $33.22.

Is Kodiak Sciences Inc overvalued?

Kodiak Sciences Inc carries a Smart Value Score of 25/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Kodiak Sciences Inc (KOD)?

The 12-month analyst consensus target is $69.60, about 109.5% above the current $33.22. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Kodiak Sciences Inc's Altman Z-Score is -7.30, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio—
ROE-205.76%
Beta2.18
50D MA$39.05
200D MA$33.78
Shares out0.06B
Float0.04B
Short ratio—
Avg volume0.6M

Performance

1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—